youtube_live
Q3 2026 earnings • released • EPS beat +54.40% • Revenue beat +9.44%
See resultschevron_right
DOC:NYSE
Healthpeak Properties, Inc
$19.48
arrow_upward
+2.34%(+0.44) 1D
$19.43
arrow_downward
-0.24% (-0.046)bedtimeAfter hours
Closed: Nov 2, 4:00:04 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DOC...
Open
$19.21
High
$19.61
Low
$18.99
Mkt. cap
13.43B
Avg. vol.
5.94M
Volume
9.58M
Dividend
6.26%
Quarterly dividend
$0.31
Ex-dividend date
Dec 18, 2026
P/E ratio
55.70
52-wk high
$22.95
52-wk low
$15.70
EPS
$0.35
Beta
1.03
Shares outstanding
689.53M
No. of employees
411
Open
$19.21
High
$19.61
Low
$18.99
Mkt. cap
13.43B
Avg. vol.
5.94M
Volume
9.58M
Dividend
6.26%
Quarterly dividend
$0.31
Ex-dividend date
Dec 18, 2026
P/E ratio
55.70
52-wk high
$22.95
52-wk low
$15.70
EPS
$0.35
Beta
1.03
Shares outstanding
689.53M
No. of employees
411
News stories
From web sources and news partners
Investing.com
·
1 hour ago
Healthpeak Properties earnings missed by $0.03, revenue topped estimates
GuruFocus
·
3 hours ago
Healthpeak Properties (DOC) Shares Slip After Q3 Results Despite Revenue Beat
Zacks
·
3 hours ago
Healthpeak (DOC) Q3 FFO and Revenues Surpass Estimates
Profile
Healthpeak Properties, Inc. is an American real estate investment trust that invests in senior housing, life science labs, and medical offices. As of December 31, 2025, the company owned interests in 689 properties. Wikipedia
About Healthpeak Properties, Inc
CEOScott M. Brinker
Employees411
FoundedMar 1985
HeadquartersDenver, Colorado, United States
SectorReal estate investment trust
Websitehcpi.com
Analyst ratings
Based on 13 analysts giving stock ratings to DOC in the past 3 months
Hold
Buy
2
Hold
11
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for DOC in the last 3 months.
Highest
Current $19.48
$25.00 (+28.34%)
Average
$21.73 (+11.55%)
Lowest
$19.00 (-2.46%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
John Kilichowski Wells Fargo | Hold | Reiterated | $19.00 | -2.5% | 10/19/2026 |
Michael Goldsmith UBS | Hold | Reiterated | $20.00 | +2.7% | 10/13/2026 |
Richard Hightower Barclays | Hold | Maintained | $21.00 | +7.8% | 10/13/2026 |
Dave Rodgers Raymond James | Hold | Maintained | - | - | 10/06/2026 |
Richard Anderson Cantor Fitzgerald | Hold | Maintained | - | - | 09/28/2026 |
James Kammert Evercore ISI | Hold | Maintained | $22.00 | +12.9% | 09/21/2026 |
Joe Dickstein Jefferies | Hold | Initiated | $21.00 | +7.8% | 09/15/2026 |
Farrell Granath Bank of America Securities | Buy | Maintained | $25.00 | +28.3% | 08/24/2026 |
Michael Mueller J.P. Morgan | Hold | Maintained | $22.00 | +12.9% | 08/18/2026 |
Nicholas Joseph Citi | Hold | Maintained | $22.00 | +12.9% | 08/11/2026 |
Michael Carroll RBC Capital | Buy | Maintained | $24.00 | +23.2% | 08/10/2026 |
Nicholas Yulico Scotiabank | Hold | Maintained | $21.00 | +7.8% | 08/05/2026 |
Ronald Kamdem Morgan Stanley | Hold | Maintained | $22.00 | +12.9% | 08/05/2026 |
Vikram Malhotra Mizuho Securities | Buy | Maintained | $24.00 | +23.2% | 07/06/2026 |
Unknown Analyst Raymond James | Hold | Initiated | $24.00 | +23.2% | 06/16/2026 |
Juan C. Sanabria BMO Capital | Buy | Maintained | $24.00 | +23.2% | 06/15/2026 |
Wes Golladay Robert W. Baird | Buy | Maintained | $21.00 | +7.8% | 05/13/2026 |
Marie Ferguson Argus Research | Hold | Downgraded | - | - | 02/05/2026 |
Last report
Nov 3, 2026
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$0.04 / $0.03
+54.40%beat
arrow_upward
Revenue / Est. (USD)
813.69M / 743.51M
+9.44%beat
arrow_upward
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 705.87M | 719.40M | 752.95M | 771.58M |
Cost of goods sold | 292.34M | 279.33M | 345.96M | 342.30M |
Cost of revenue | 292.34M | 279.33M | 345.96M | 342.30M |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 19.91M | 33.63M | 24.59M | 22.52M |
Operating expense | 282.22M | 295.71M | 314.32M | 305.91M |
Total operating expenses | 574.57M | 575.04M | 660.28M | 648.20M |
Operating income | 131.31M | 144.36M | 92.67M | 123.38M |
Other non operating income | 1.16M | 11.14M | 1.47M | 12.35M |
EBT including unusual items | -111.05M | 127.82M | 199.91M | 61.84M |
EBT excluding unusual items | -120.61M | 77.57M | 11.12M | 45.96M |
Income tax expense | -1.21M | 6.03M | 254.00K | -1.40M |
Effective tax rate | 1.09% | 4.72% | 0.13% | -2.27% |
Other operating expenses | - | - | - | - |
Net income | -117.12M | 113.97M | 193.63M | 52.82M |
Net profit margin | -16.59% | 15.84% | 25.72% | 6.85% |
Earnings per share | -0.18 | 0.10 | - | - |
Interest and investment income | - | - | - | - |
Interest expense | -76.78M | -80.64M | -87.29M | -92.28M |
Net interest expenses | -76.78M | -80.64M | -87.29M | -92.28M |
Depreciation and amortization charges | 262.32M | 262.09M | 289.73M | 283.39M |
EBITDA | 393.62M | 369.95M | 375.81M | 400.46M |
Gain or loss from assets sale | -11.50M | -56.35M | -50.67M | -9.99M |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events